Literature DB >> 9197529

Human papillomavirus infection and risk determinants for squamous intraepithelial lesion and cervical cancer in Japan.

T Sasagawa1, Y Dong, K Saijoh, S Satake, M Tateno, M Inoue.   

Abstract

A case control design was used to investigate human papillomavirus (HPV) prevalence and risk factors associated with development of cervical squamous intraepithelial lesion (SIL) and cervical cancer (CC) in Japan. One hundred and twenty-three women with histologically confirmed SIL or CC were compared to a control group of 778 cytologically normal women. With the use of a polymerase chain reaction (PCR)-based method for detection of low-risk (types 6 and 11) and high-risk (types 16, 18, 31, 33, 35, 52 and 58) HPVs, a high prevalence of HPV infection was observed in smokers among the controls. Logistic regression analysis demonstrated that high-risk HPV infection was the most significant risk determinant for LSIL (OR=9.4, 95% CI=4.5-19), HSIL (OR=77, 95% CI=28-217) and CC (OR=97, 95% CI=35-269). It also showed that unmarried women, women married for 5 to 19 years and smokers represented high risk groups for SIL, while smokers and women with a history of many pregnancies/parities had increased risk for CC. Smoking was the only HPV infection-independent factor for CC, suggesting that smoking may have a carcinogenic effect on the cervix. Since neither history of other cancer nor family cancer history was associated with SIL or CC, genetic factors appear to play little role in cervical carcinogenesis. The risk for cervical neoplasia due to HPV infection increased after marriage in Japan, suggesting a role for husbands as carriers of HPV transmission. Protection from high-risk HPV infection may be of greatest importance for prevention of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9197529      PMCID: PMC5921426          DOI: 10.1111/j.1349-7006.1997.tb00392.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

Review 1.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers.

Authors:  H zur Hausen
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

2.  Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions.

Authors:  T Matsukura; M Sugase
Journal:  Int J Cancer       Date:  1995-03-29       Impact factor: 7.396

3.  Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.

Authors:  H M Bauer; A Hildesheim; M H Schiffman; A G Glass; B B Rush; D R Scott; D M Cadell; R J Kurman; M M Manos
Journal:  Sex Transm Dis       Date:  1993 Sep-Oct       Impact factor: 2.830

4.  Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction.

Authors:  Y Fujinaga; M Shimada; K Okazawa; M Fukushima; I Kato; K Fujinaga
Journal:  J Gen Virol       Date:  1991-05       Impact factor: 3.891

5.  Human papillomavirus (HPV) type 16 in semen of partners of women with HPV infection.

Authors:  M Inoue; A Nakazawa; M Fujita; O Tanizawa
Journal:  Lancet       Date:  1992-05-02       Impact factor: 79.321

6.  Human papillomavirus--the most significant risk determinant of cervical intraepithelial neoplasia.

Authors:  S K Kjaer; A J van den Brule; J E Bock; P A Poll; G Engholm; M E Sherman; J M Walboomers; C J Meijer
Journal:  Int J Cancer       Date:  1996-03-01       Impact factor: 7.396

7.  Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction.

Authors:  A M de Roda Husman; J M Walboomers; C J Meijer; E K Risse; M E Schipper; T M Helmerhorst; O P Bleker; H Delius; A J van den Brule; P J Snijders
Journal:  Int J Cancer       Date:  1994-03-15       Impact factor: 7.396

8.  Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Authors:  J P Figueroa; E Ward; T E Luthi; S H Vermund; A R Brathwaite; R D Burk
Journal:  Sex Transm Dis       Date:  1995 Mar-Apr       Impact factor: 2.830

9.  Detection of human papillomavirus type 16 in sexual partners of patients having cervical cancer by polymerase chain reaction.

Authors:  A Nakazawa; M Inoue; M Fujita; O Tanizawa; A Hakura
Journal:  Jpn J Cancer Res       Date:  1991-11

10.  Subsite (cervix/endometrium)-specific risk and protective factors in uterus cancer.

Authors:  K Hirose; K Tajima; N Hamajima; T Takezaki; M Inoue; T Kuroishi; K Kuzuya; S Nakamura; S Tokudome
Journal:  Jpn J Cancer Res       Date:  1996-09
View more
  2 in total

1.  Liquid-based urine cytology as a tool for detection of human papillomavirus, Mycoplasma spp., and Ureaplasma spp. in men.

Authors:  Shohei Kawaguchi; Kazuyoshi Shigehara; Toshiyuki Sasagawa; Masayoshi Shimamura; Takao Nakashima; Kazuhiro Sugimoto; Kazufumi Nakashima; Keiichi Furubayashi; Mikio Namiki
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

2.  Cervical cancer management in Zimbabwe (2019-2020).

Authors:  Petmore Zibako; Nomsa Tsikai; Sarah Manyame; Themba G Ginindza
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.